Skip to main content
SpringerLink
Log in

Introduction

  • Chapter
  • First Online:
Medical Management of Glaucoma

Abstract

The term glaucoma encompasses a number of diseases in which there is a progressive loss of retinal ganglion cells (RGC) with corresponding visual field loss that results in a characteristic “cupped” appearance in the optic nerve head. Glaucoma results in an irreversible loss of visual field, usually starting in the periphery, and sometimes affecting the central visual field first, but leading to varying degrees of visual disability and, in a small but significant proportion of patients, blindness.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hoste AM. New insights into the subjective perception of visual field defects. Bull Soc Belge Ophthalmol. 2003;287:65-71.

    Google Scholar 

  2. American Academy of Ophthalmology: The Eye M.D. Association. In: 2008-2009 Basic and Clinical Science Course, Section 10: Glaucoma. San Francisco, CA: American Academy of Ophthalmology; 2011.

    Google Scholar 

  3. Kerrigan-Baumrind LA, Quigley HA, Pease ME, et al. Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons. Invest Ophthalmol Vis Sci. 2000;41:741-748.

    Google Scholar 

  4. World Health Organization. Magnitude and causes of visual impairment. Fact Sheet N°282. 2011. Available at www.who.int/mediacentre/factsheets/fs282/en/. Accessed August 7, 2013.

  5. Resnikoff S, Pascolini D, Etya’ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844-851.

    Google Scholar 

  6. Friedman DS, Wolfs RC, O’Colmain BJ, et al. Prevalence of open-angle glaucoma among adults in the United States. Arch Ophthalmol. 2004;122:532-538.

    Google Scholar 

  7. de Voogd S, Ikram MK, Wolfs RCW, et al. Incidence of open-angle glaucoma in a general elderly population: the Rotterdam Study. Ophthalmology. 2005;112:1487-1493.

    Google Scholar 

  8. National Collaborating Centre for Acute Care. NHS. National Institute for Health and Clinical Excellence. Glaucoma: Diagnosis and management of chronic open angle glaucoma and ocular hypertension. Available at: www.nice.org.uk/nicemedia/pdf/CG85NICEGuideline.pdf. Published April 2009. Accessed August 7, 2013.

  9. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262-267.

    Google Scholar 

  10. Wensor MD, McCarty CA, Stanislavsky YL, et al. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology. 1998;105:733-739.

    Google Scholar 

  11. Mitchell P, Smith W, Attebo K, et al. Prevalence of open-angle glaucoma in Australia. The Blue Mountains Eye Study. Ophthalmology. 1996; 103:1661-1669.

    Google Scholar 

  12. Dielemans I, Vingerling JR, Wolfs RC, et al. The prevalence of primary open-angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 1994;101:1851-1855.

    Google Scholar 

  13. Quigley HA, West SK, Rodriguez J, et al. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119:1819-1826.

    Google Scholar 

  14. Varma R, Ying-Lai M, Francis BA, et al. Prevalence of open-angle glaucoma and ocular hypertension in Latinos: the Los Angeles Latino Eye Study. Ophthalmology. 2004;111:1439-1448.

    Google Scholar 

  15. Vijaya L, George R, Paul PG, et al. Prevalence of open-angle glaucoma in a rural south Indian population. Invest Ophthalmol Vis Sci. 2005;46:4461-4467.

    Google Scholar 

  16. Vijaya L, George R, Baskaran M, et al. Prevalence of primary open-angle glaucoma in an urban south Indian population and comparison with a rural population. The Chennai Glaucoma Study. Ophthalmology. 2008;115:648-654.

    Google Scholar 

  17. Thomas R, Sekhar GC, Parikh R. Primary angle-closure glaucoma: a developing world perspective. Clin Exp Ophthalmol. 2007;35:374-378.

    Google Scholar 

  18. Foster PJ, Baasanhu J, Alsbirk PH, et al. Glaucoma in Mongolia. A population-based survey in Hovsgol province, northern Mongolia. Arch Ophthalmol. 1996;114:1235-1241.

    Google Scholar 

  19. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124:1754-1760.

    Google Scholar 

  20. Rouland JF, Berdeaux G, Lafuma A. The economic burden of glaucoma and ocular hypertension: implications for patient management: a review. Drugs Aging. 2005;22:315-321.

    Google Scholar 

  21. Altangerel U, Spaeth GL, Rhee DJ. Visual function, disability, and psychological impact of glaucoma. Curr Opin Ophthalmol. 2003;14:100-105.

    Google Scholar 

  22. Nutheti R, Shamanna BR, Nirmalan PK, et al. Impact of impaired vision and eye disease on quality of life in Andhra Pradesh. Invest Ophthalmol Vis Sci. 2006;47:4742-4748.

    Google Scholar 

  23. Gupta V, Srinivasan G, Mei SS, et al. Utility values among glaucoma patients: an impact on the quality of life. Br J Ophthalmol. 2005;89:1241-1244.

    Google Scholar 

  24. Uenishi Y, Tsumura H, Miki T, et al. Quality of life of elderly Japanese patients with glaucoma. Int J Nurs Pract. 2003;9:18-25.

    Google Scholar 

  25. McKean-Cowdin R, Wang Y, Wu J, et al. Los Angeles Latino Eye Study Group. Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115:941-948.

    Google Scholar 

  26. Freeman EE, Munoz B, West SK, et al. Glaucoma and quality of life. The Salisbury Eye Evaluation. Ophthalmology. 2008;115:233-238.

    Google Scholar 

  27. Ramulu P. Glaucoma and disability: which tasks are affected, and at what stage of disease? Curr Opin Ophthalmol. 2009;20:92-98.

    Google Scholar 

  28. Friedman DS, Freeman E, Munoz B, et al. Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007;114:2232-2237.

    Google Scholar 

  29. Noe G, Ferraro J, Lamoureux E, et al. Associations between glaucomatous visual field loss and participation in activities of daily living. Clin Experiment Ophthalmol. 2003;31:482-486.

    Google Scholar 

  30. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004;122:477-485.

    Google Scholar 

  31. Fraser S, Bunce C, Wormald R. Risk factors for late presentation in chronic glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2251-2257.

    Google Scholar 

  32. Fraser S, Bunce C, Wormald R. Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol. 1999;83:24-28.

    Google Scholar 

  33. Ramachandran VS, Gregory RL. Perceptual filling in of artificially induced scotomas in human vision. Nature. 1991;350:699-702.

    Google Scholar 

  34. Healey PR. Screening for Glaucoma. In: Shaarawy T, Sherwood MB, Hitchings RA, Crowston JG, eds. Glaucoma. New York, NY: Elsevier; 2009:15-23.

    Google Scholar 

  35. Burr JM, Mowatt G, Hernandez R, et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess. 2007;11:iii-iv, ix-x, 1-190.

    Google Scholar 

  36. Tielsch JM, Katz J, Singh K, et al. A population-based evaluation of glaucoma screening: the Baltimore Eye Survey. Am J Epidemiol. 1991;134:1102-1110.

    Google Scholar 

  37. The Glaucoma Screening Platform Study Group. Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study. BMC Med Res Methodol. 2011;11:54.

    Google Scholar 

  38. Vaahtoranta-Lehtonen H, Tuulonen A, Aronen P, et al. Cost effectiveness and cost utility of an organized screening programme for glaucoma. Acta Ophthalmol Scand. 2007;85:508-518.

    Google Scholar 

  39. Fraser S, Bunce C, Wormald R, Brunner E. Deprivation and late presentation of glaucoma: case-control study. BMJ. 2001;322:639-643.

    Google Scholar 

  40. Brusini P, Johnson CA. Staging functional damage in glaucoma: review of different classification methods. Surv Ophthalmol. 2007;52:156-179.

    Google Scholar 

  41. Hodapp E, Parrish RK, Anderson DR. Clinical decisions in glaucoma. St Louis, MO: The C.V. Mosby Co.; 1993:52-61.

    Google Scholar 

  42. The AGIS Investigators. Advanced glaucoma intervention study. 2. Field scoring and reliability. Ophthalmology. 1994;101:1445-1455.

    Google Scholar 

  43. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720.

    Google Scholar 

  44. Hitchings RA. A practical approach to the management of normal tension glaucoma. In: Grehn F, Stamper R, eds. Essentials in Ophthalmology: Glaucoma. Berlin, Germany: Springer-Verlag; 2004.

    Google Scholar 

  45. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 3rd edition. Savona, Italy: Dogma; 2008.

    Google Scholar 

  46. Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644-649.

    Google Scholar 

  47. Jonas JB, Bergua A, Schmitz-Valckenberg P, et al. Ranking of optic disc variables for detection of glaucomatous optic nerve damage. Invest Ophthalmol Vis Sci. 2000;41:1764-1773.

    Google Scholar 

  48. Brandt JD. Congenital glaucoma. In: Yanoff M, Duker JS, eds. Ophthalmology. London, UK: Mosby; 1999.

    Google Scholar 

  49. Mitchell P, Lee AJ, Rochtchina E, et al. Open-angle glaucoma and systemic hypertension: the Blue Mountains Eye Study. J Glaucoma. 2004;13:319-326.

    Google Scholar 

  50. Mitchell P. Session 2. The infinite improbability drive – Epidemiology Co-Chairs: Richard Wormald and Paul Chew. Diabetes, blood pressure caffeine: Is it or is it not! The Glaucoma Galaxy: A Hitch-Hikers Guide – Perspectives from a career under pressure. In: Barton K, ed. International Glaucoma Review: The Journal for the World Glaucoma Association. 2008;10-1:20-22.

    Google Scholar 

  51. Flammer J, Haefliger IO, Orgul S, Resink T. Vascular dysregulation: a principal risk factor for glaucomatous damage? J Glaucoma. 1999;8:212-219.

    Google Scholar 

  52. Leske MC, Heijl A, Hyman L, et al. EMGT Group. Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology. 2007;114:1965-1972.

    Google Scholar 

  53. Leske MC, Wu SY, Nemesure B, et al. Incident open-angle glaucoma and blood pressure. Arch Ophthalmol. 2002;120:954-959.

    Google Scholar 

  54. Wilson MR, Gallardo M. Glaucoma risk factors: ethnicity and glaucoma. In: Schacknow PN, Samples JR, eds. The Glaucoma Book: A Practical Evidence-Based Approach to Patient Care. New York, NY: Springer Science+Business Media, LLC; 2010:101-109.

    Google Scholar 

  55. Wormald RP, Basauri E, Wright LA, et al. The African Caribbean Eye Survey: risk factors for glaucoma in a sample of African Caribbean people living in London. Eye. 1994;8:315-320.

    Google Scholar 

  56. Doshi V, Ying-Lai M, Azen SP, et al; the Los Angeles Latino Eye Study Group. Sociodemographic, family history, and lifestyle risk factors for open-angle glaucoma and ocular hypertension: the Los Angeles Latino Eye Study. Ophthalmology. 2008;115:639-647.

    Google Scholar 

  57. Berdahl JP, Allingham RR, Johnson DH. Cerebrospinal fluid pressure is decreased in primary open-angle glaucoma. Ophthalmology. 2008;115:763-768.

    Google Scholar 

  58. Gedde SJ, Budenz DL, Anderson DR. Primary open-angle glaucoma and normal-tension glaucoma. In: Parrish R II, Budenz DL, eds. The University of Miami Bascom Palmer Eye Institute Atlas of Ophthalmology. Philadelphia, PA: Current Medicine Group LLC; 2000.

    Google Scholar 

  59. Caprioli J, Coleman AL; Blood Flow in Glaucoma Discussion. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol. 2010;149:704-712.

    Google Scholar 

  60. Fraser S, Wormald R. Epidemiology of glaucoma. In Yanoff M, Duker JS, eds. Ophthalmology. London, UK: Mosby; 1999.

    Google Scholar 

  61. Klein BE, Klein R, Sponsel WE, et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 1992;99:1499-1504.

    Google Scholar 

  62. Tielsch JM, Sommer A, Katz J, et al. Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA. 1991;266:369-374.

    Google Scholar 

  63. Leske MC, Connell AM, Schachat AP, et al. The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol. 1994;112:821-829.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Moorfields Eye Hospital, London, UK

    Keith Barton & Roger A. Hitchings

Authors
  1. Keith Barton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roger A. Hitchings
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Kittner Distinguished Professor and Chair of Ophthalmology, UNC Health Care System, Chapel Hill, North Carolina, USA

    Donald L. Budenz

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Healthcare

About this chapter

Cite this chapter

Barton, K., Hitchings, R.A. (2013). Introduction. In: Budenz, D. (eds) Medical Management of Glaucoma. Springer Healthcare, Tarporley. https://doi.org/10.1007/978-1-907673-44-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-907673-44-3_1

  • Published:

  • Publisher Name: Springer Healthcare, Tarporley

  • Print ISBN: 978-1-858734-30-9

  • Online ISBN: 978-1-907673-44-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation